Renal protective role of atrial natriuretic peptide in acute sodium overload-induced inflammatory response

American Journal of Nephrology

Volumn 26, Issue 6, 2007, Pages 590-601

  Rosón, María Inés ^a   Toblli, Jorge E ^b   Della Penna, Silvana L ^b   Gorzalczany, Susana ^b   Pandolfo, Marcela ^b   Cavallero, Susana ^b   Fernández, Belisario E ^b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b NONE

Author keywords

Angiotensin II; Atrial natriuretic peptide; Sodium overload

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; CREATININE; HYPOXIA INDUCIBLE TRANSCRIPTION FACTOR 1 ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RANTES; SODIUM; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE MARKER; DOWN REGULATION; DRUG EFFECT; DRUG INFUSION; HORMONE ACTION; HYPOXIA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTOXICATION; KIDNEY PARENCHYMA; KIDNEY TUBULE ABSORPTION; MALE; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; SODIUM ABSORPTION; SODIUM OVERLOAD; SPRAGUE DAWLEY RAT;

ANGIOTENSIN II; ANIMALS; ANOXIA; ATRIAL NATRIURETIC FACTOR; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KIDNEY MEDULLA; KIDNEY TUBULES; MALE; NEPHRITIS, INTERSTITIAL; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; SALINE SOLUTION, HYPERTONIC; SODIUM;

EID: 33846419117     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098148     Document Type: Article

References (40)

1. Brezis M, Heyman SN, Epstein FH: Determinants of intrarenal oxygenation. II. Hemodynamic effects. Am J Physiol 1994;267:F1063-F1068.
2. Sutton TA, Molitoris BA: Mechanisms of cellular injury in ischemic acute renal failure. Semin Nephrol 1998;18:490-497.
3. Uchida T, Rossignol F, Matthay MA, Mounier R, Couette S, Clottes E, Clerici C: Prolonged hypoxia differentially regulates hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression in lung epithelial cells: implication of natural antisense HIF-1alpha. J Biol Chem 2004;279:14871-14878.
4. Maxwell P: HIF-1: An oxygen response system with special relevance to the kidney. J Am Soc Nephrol 2003;14:2712-2722.
5. Brezis M, Rosen S: Hypoxia of the renal medulla. Its implications for disease. N Engl J Med 1995;332:647-655.
6. Manotham K, Tanaka T, Ohse T, Kojima I, Miyata T, Inagi R, Tanaka H, Sassa R, Fujita T, Nangaku M: A biologic role of HIF-1 in the renal medulla. Kidney Int 2005;67:1428-1439.
7. Siragi HM: Angiotensin II compartmentalization within the kidney: effects of salt diet and blood pressure alterations. Curr Opin Nephrol Hypertens 2006;15:50-53.
8. Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J: Inflammation and angiotensin II. Int J Biochem Cell Biol 2003;35:881-900.
9. Li C, Sun BK, Lim SW, Song JC, Kang SW, Kim YS, Kang DH, Cha JH, Kim J, Yang CW: Combined effects of losartan and pravastatin on interstitial inflammation and fibrosis in chronic cyclosporine-induced nephropathy. Transplantation 2005;79:1522-1529.
10. Sun BK, Li C, Lim SW, Choi BS, Lee SH, Kim YS, Bang BK, Yang CW: Blockade of angiotensin II with losartan attenuates transforming growth factor-beta 1 inducible gene-h3 (betaig-h3) expression in a model of chronic cyclosporine nephrotoxicity. Nephron Exp Nephrol 2005;99:E9-E16.
11. Pandey KN: Biology of natriuretic peptides and their receptors. Peptides 2005;26:901-932.
12. Kiemer AK, Furst R, Vollmar AM: Vasoprotective actions of the atrial natriuretic peptide. Curr Med Chem Cardiovasc Hematol Agents 2005;3:11-21.
13. Calderone A: Natriuretic peptides and the management of heart failure. Minerva Endocrinol 2004;29:113-127.
14. Chen YF: Atrial natriuretic peptide in hypoxia. Peptides 2005;26:1068-1077.
15. Kiemer AK, Weber NC, Vollmar AM: Induction of IkappaB: atrial natriuretic peptide as a regulator of the NF-kappaB pathway. Biochem Biophys Res Commun 2002;295:1068-1076.
16. Vollmar AM: The role of atrial natriuretic peptide in the immune system. Peptides 2005;26:1086-1094.
17. Chatterjee PK, Hawksworth GM, McLay JS: Cytokine-stimulated nitric oxide production in the human renal proximal tubule and its modulation by natriuretic peptides: a novel immunomodulatory mechanism? Exp Nephrol 1999;7:438-448.
18. Roson MI, Cavallero S, Della Penna S: Acute sodium overload produces renal tubulointerstitial inflammation in normal rats. Kidney Int 2006;70:1439-1446.
19. Hsu SM, Raine L, Fanger H: Use of avidinbiotin-peroxidase complex (ABC) immunoperoxidase techniques: a comparision between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-580.
20. Dunn BR, Ichikawa I, Pfeffer JM: Renal and systemic hemodynamic effects of synthetic atrial natriuretic peptide in the anesthetized rat. Circ Res 1986;59:237-246.
21. Hirata Y, Ishii M, Sugimoto T, Matsuoka H, Sugimoto T, Kangawa K, Matsuo H: The effects of human atrial 28-amino acid peptide on systemic and renal hemodynamics in anesthetized rats. Circ Res 1985;57:634-639.
22. Lassen NA, Munk O, Thaysen JH: Oxygen consumption and sodium reabsorption in the kidney. Acta Physiol Scand 1961;51:371-384.
23. Lang RE, Tholken H, Ganten D, Luft FC, Ruskoaho H, Unger T: Atrial natriuretic factor; a circulating hormone stimulated by volume loading. Nature 1985;314:828-834.
24. Klinger JR, Pietras L, Warburton R, Hill NS: Reduced oxygen tension increases atrial natriuretic peptide release from atrial cardiocytes. Exp Biol Med 2001;226:847-853.
25. Chun YS, Hyun JY, Kwak YG, Kim IS, Kim CH, Choi E, Kim MS, Park JW: Hypoxic activation of the atrial natriuretic peptide gene promoter through direct and indirect actions of hypoxia-inducible factor-1. Biochem J 2003;370:149-157.
26. Semenza GL: HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol 2001;13:167-171.
27. Epstein FH: Oxygen and renal metabolism. Kidney Int 1997;51:381-385.
28. Sanjuan-Pla A, Cervera AM, Apostolova N, Garcia Bour R, Victor VM, Murphy MP, Mc Creath KJ: A targeted antioxidant reveals the importance of mitochondrial reactive oxygen species in the hypoxic signaling of HIF-1alpha. FEBS Lett 2005;579:2669-2674.
29. Ruiz-Ortega M, Ruperez M, Lorenzo O, Esteban V, Blanco J, Mezzano S, Egido J: Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int 2002;82(suppl):12-22.
30. Li N, Yi FX, Spurrier JL, Bobrowitz CA, Zou AP: Production of superoxide through NADH oxidase in thick ascending limb of Henle's loop in rat kidney. Am J Physiol Renal Physiol 2002;282:F1111-F1119.
31. Zou AP, Li N, Cowley AW: Production and actions of superoxide in renal medulla. Hypertension 2001;37:547-553.
32. Rodriguez-Iturbe B, Pons H, Quiroz Y, Gordon K, Rincon J, Chavez M, Parra G, Herrera-Acosta J, Gomez-Garre D, Largo R, Ejido J, Johnson RJ: Mycofenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney Int 2001;59:2222-2232.
33. Beltowski J, Wójcicka G: Regulation of renal tubular sodium transport by cardiac natriuretic peptides: two decades of research. Med Sci Monit 2002;8:RA39-RA52.
34. Schreck R, Rieber P, Baeuerle PA: Reactive oxygen intermediates as apparently widely used messengers in the activation of the NFkB transcription factor and HIV. EMBO J 1991;10:2247-2258.
35. Nishiyama A, Yoshizumi M, Rahman M, Kobori H, Seth DM, Miyatake A, Zhang GX, Yao L, Hitomi H, Shokoji T, Kiyomoyo H, Kimura S, Tamaki T, Kohono M, Abe Y: Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats. Kidney Int 2004;65:972-981.
36. Campbell DJ, Lawrence AC, Towrie A, Kladis A, Valentijn AJ: Differential regulation of angiotensin levels in plasma and kidney of the rat. Hypertension 1991;18:763-773.
37. Kiemer AK, Weber NC, Furst R, Bildner M, Kulhanek-Heinze S, Vollmar AM: Inhibition of p38 MAPK activation via induction of MKP-1: atrial natriuretic peptide reduces TNF-alpha-induced actin polymerization and endothelial permeability. Circ Res 2002;90:874-881.
38. Kiemer AK, Lehner MD, Hartung T, Vollmar AM: Inhibition of cyclooxygenase-2 by natriuretic peptide. Endocrinology 2002;143:846-852.
39. Kiemer AK, Vollmar AM: Autocrine regulation of inducible nitric-oxide synthase in macrophages by atrial natriuretic peptide. J Biol Chem 1998;273:13444-13451.
40. Irwin DC, Tissot van Patot MC, Tucker A, Bower R: Direct ANP inhibition of hypoxia-induced inflammatory pathways in pulmonary microvascular and macrovascular endothelial monolayers. Am J Physiol Lung Cell Mol Physiol 2005;288:L849-L859.